iRadimed Corporation (IRMD) News
Filter IRMD News Items
IRMD News Results
|Loading, please wait...|
IRMD News Highlights
- IRMD's 30 day story count now stands at 7.
- Over the past 22 days, the trend for IRMD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- BOOT, PRDO and TOP are the most mentioned tickers in articles about IRMD.
Latest IRMD News From Around the Web
Below are the latest news stories about IRADIMED CORP that investors may wish to consider to help them evaluate IRMD as an investment opportunity.
On September 13, 2023, Roger Susi, the CEO, President, Chairman, and 10% Owner of iRadimed Corp (NASDAQ:IRMD), sold 10,000 shares of the company.
iRadimed, PulteGroup and NVIDIA have been highlighted in this Screen of The Week article.
WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences. Iradimed management is scheduled to participate in investor meetings at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday and Wednesday, September 12-13, 2023, at the Lotte New York Palace Hotel in New York City. Iradimed management will also be participating in investor meet
Key Insights Insiders appear to have a vested interest in IRadimed's growth, as seen by their sizeable ownership The...
iRadimed (IRMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Perdoceo Education, Boot Barn and iRadimed have been highlighted in this Screen of The Week article.
Perdoceo Education (PRDO), Boot Barn (BOOT) and iRadimed (IRMD) have been selected as the top picks with a high net income ratio.
Key Insights The projected fair value for IRadimed is US$36.31 based on 2 Stage Free Cash Flow to Equity IRadimed is...
iRadimed (IRMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
iRadimed (IRMD) delivered earnings and revenue surprises of 16.13% and 2.74%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?